Robert Dean, MBA Merck & Co., Inc.

Bob is currently a Director/Team Leader in Merck's Office of Advertising and Promotion Review. Bob started his career as an in-process QC Chemist with Abbott Laboratories. He performed similar duties for Alpharma before transitioning to field sales with UCB Pharma, Alza, and eventually J&J.  Bob left industry for public service at FDA where began his role in DDMAC as a Regulatory Review Officer.  As DDMAC grew and transitioned to OPDP, Bob's responsibilities increased as he assumed the role of Division Director, Division of Direct to Consumer Promotion (now the Division of Advertising and Promotion Review 2). During his time at FDA, Bob was instrumental in leading several high profile efforts for OPDP, including; Issuing 5 enforcement actions on the same day to manufacturers of ADHD medications, issuance of 14 Google Sponsored Link letters, and co-developer of FDA's Bad Ad Program.